Vertaling van "information required for healthcare " (Nederlands → Frans) :

Ook in Europese context wordt de toestemming van de patiënt als “good medical practice” bestempeld, zoals blijkt: “Although consent can be presumed for the recording and sharing of information required for healthcare within the immediate healthcare team, it is good practice to obtain specific consent for this process, particularly in relation to sensitive information.
Le consentement du patient est également considéré dans le contexte européen comme une « good medical practice », ainsi : « Bien que le consentement soit présumé pour l’enregistrement et le partage d’informations requises pour la prestation des soins de santé au sein de l’équipe directe de soins, il est judicieux, dans la pratique, d’obtenir un accord spécifique pour ceci, particulièrement pour ce qui concerne des informations sensibles.

In close cooperation with Mdeon, the FAMHP has mainly focused on the provision of information to the relevant parties, i.e. companies and healthcare professionals, during this first operational year A “contact point” collects and processes information about actions that may constitute an infringement of the legal requirements about advertising. In terms of advertising for healthcare professionals, attention is particularly being focused at present on the conformity of the legally required information
In close cooperation with Mdeon, the FAMHP has mainly focused on the provision of information to the relevant parties, i.e. companies and healthcare professionals, during this first operational year A “contact point” collects and processes information about actions that may constitute an infringement of the legal requirements about advertising. In terms of advertising for healthcare professionals, attention is particularly being focused at present on the conformity of the legally required information

The BUM department is legally required to provide support with putting online the list of medicines authorised in Belgium for new medicine MA and of the official information (Summary of Product Characteristics for healthcare professionals and leaflet for the general public).
The BUM department is legally required to provide support with putting online the list of medicines authorised in Belgium for new medicine MA and of the official information (Summary of Product Characteristics for healthcare professionals and leaflet for the general public).

In terms of premiums and benefits, since 1 January 2007 there has been a requirement to request a prior licence when a pharmaceutical company or company selling medical devices wishes to pay the costs of a healthcare professional participating in a scientific gathering including at least one overnight stay.
In terms of premiums and benefits, since 1 January 2007 there has been a requirement to request a prior licence when a pharmaceutical company or company selling medical devices wishes to pay the costs of a healthcare professional participating in a scientific gathering including at least one overnight stay.

Since 1 January 2007, the law has been in force requiring a preliminary approval for the payment by pharmaceutical companies or producers of medical devices of the participation costs of healthcare professionals in scientific events involving at least one night’s accommodation.
Since 1 January 2007, the law has been in force requiring a preliminary approval for the payment by pharmaceutical companies or producers of medical devices of the participation costs of healthcare professionals in scientific events involving at least one night’s accommodation.

The package itself would be required to be plain coloured and to display only information (such as health warnings) required by law.
L’emballage lui-même devrait être de couleur unie et ne présenter que les informations requises par la loi (telles que les avertissements sanitaires).

In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.
In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.

In order to be efficient, prevention requires among other things the spreading of information, viz. the broadcasting of quality information via the media, colloquia, conferences, and debates. In other words, this involves constantly repeating basic notions, talking about experiences of life and death in which everyone, if they are willing to, can recognise themselves or someone else.
Pour pouvoir agir, une prévention nécessite notamment de l’information: diffuser une information de qualité par les médias, colloques, conférences, débats; c’est-à-dire répéter inlassablement des notions simples, parler d’expériences de vie, de mort dans lesquelles chacun peut, s’il se le permet, se reconnaître ou y reconnaître quelqu’un.

The database can be used to look up extensive information about authorised medicines without having to contact those responsible for providing information, as is currently the case ●● Healthcare professionals and veterinarians
The database can be used to look up extensive information about authorised medicines without having to contact those responsible for providing information, as is currently the case ●● Healthcare professionals and veterinarians

In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.
In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.